TERESA
RODRÍGUEZ RUIZ
Researcher in the period 2022-2023
Publications (14) TERESA RODRÍGUEZ RUIZ publications
2021
-
Copy neutral loh affecting the entire chromosome 6 is a frequent mechanism of hla class i alterations in cancer
Cancers, Vol. 13, Núm. 20
-
The current role of the heavy/light chain assay in the diagnosis, prognosis and monitoring of multiple myeloma: An evidence-based approach
Diagnostics, Vol. 11, Núm. 11
2019
-
A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer
Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2631-2639
2018
-
HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15
Immunogenetics, Vol. 70, Núm. 10, pp. 647-659
2017
-
Mieloma múltiple IgD: reporte de 5 casos clínicos
Revista del laboratorio clínico, Vol. 10, Núm. 2, pp. 100-104
-
Serum free light chains in the evaluation of the response to treatment and biological progression in primary amyloidosis
Revista del laboratorio clínico, Vol. 10, Núm. 3, pp. 158-161
2016
-
Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients
American Journal of Hematology, Vol. 91, Núm. 7, pp. 700-704
2015
-
Trends in survival of multiple myeloma: A thirty-year population-based study in a single institution
Cancer Epidemiology, Vol. 39, Núm. 5, pp. 693-699
2008
-
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines
Cancer Immunology, Immunotherapy, Vol. 57, Núm. 5, pp. 719-729
2007
-
Different mechanisms can lead to the same altered HLA class I phenotype in tumors
Tissue Antigens
-
Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines
BMC Cancer, Vol. 7
-
Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy
Cancer Immunology, Immunotherapy
-
Patterns of constitutive and IFN-γ inducible expression of HLA class II molecules in human melanoma cell lines
Immunogenetics, Vol. 59, Núm. 2, pp. 123-133
2005
-
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity
Cancer Immunology, Immunotherapy, Vol. 54, Núm. 2, pp. 141-148